SmallCapPower | February 2016 It’s exciting times for shareholders of Zecotek Photonics Inc. (TSXV: ZMS), as the Company is transitioning from Research & Development to revenue generation. In fact, its most recent quarter (Q2) saw a 3-fold quarter-over-quarter revenue increase and a 7-fold surge over the same period last year. And 2016 looks even brighter for Zecotek, as it has $3.2 million of orders booked and the Company is developing relationships with the fast-growing Chinese PET OEMs.
Ubika Research/SmallCapPower has received compensation from Zecotek Photonics Inc. (TSXV: ZMS) to provide analyst research coverage. For full disclosure please visit here >